mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.3 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
-0.033 |
0.4 |